Shaperon

샤페론 · 378800

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$38.2M (₩52.7B)

Overview

Company summary coming soon.

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$165.1K
▲ +1186.7% YoY
Operating profit · FY2025
−US$11.5M
Loss widened
Net income · FY2025
−US$11.3M
Loss widened

Revenue

  • FY2023US$156K
  • FY2024US$12.8K
  • FY2025US$165.1K

Operating profit

  • FY2023−US$9.6M
  • FY2024−US$11M
  • FY2025−US$11.5M

Net income

  • FY2023−US$9M
  • FY2024−US$10.8M
  • FY2025−US$11.3M

Key ratios (FY2025)

ROE
-62.8%
Debt/Eq
12.7%
Op. margin
-6952.9%
Net margin
-6816.3%
Rev. YoY
▲ +1186.7%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.